I. Background 1. Legal Classification and International Systems for Monitoring Novel Psychoactive Substances 2. Availability and Supply of Novel Psychoactive Substances 3. Prevalence of Use of Novel Psychoactive Substances 4. Pharmacological Profiling of Novel Psychoactive Substances 5. Novel methods of NPS detection and data triangulation 6. Social issues in the use of novel psychoactive substances 7. General management of the patient with Novel Psychoactive Substance Toxicity 8. Addiction and treatment of Novel Psychoactive Substance dependence
II. Analytical Techniques 9. Analytical techniques for the detection of novel psychoactive substances and their metabolites
III. Individual Novel Psychoactive Substances 10. Synthetic Amphetamines including novel MDMA analogues 11. Pharmacology and Toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) Hallucinogens 12. 1-Benzylpiperazine and other Piperazine-based stimulants 13. Cathinones 14. Arylcyclohexamines 15. Synthetic cannabinoids 16. Novel opioids 17. Novel benzodiazepines 18. Tryptamines